Xilio Therapeutics, Inc.XLONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-177.78%
↓ 14% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-156.01%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -177.78% | +80.6% |
| 2024 | -914.27% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | - |
| 2019 | 0.00% | - |